Breast Cancer: Targets and Therapy
Volume 10, 2018 - Issue
Open access
86
Views
8
CrossRef citations to date
0
Altmetric
Review
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date
Carmen CriscitielloEuropean Institute of Oncology, Milano, ItalyCorrespondence[email protected]
, Giulia VialeEuropean Institute of Oncology, Milano, Italy
, Giuseppe CuriglianoEuropean Institute of Oncology, Milano, Italy
& Aron GoldhirschEuropean Institute of Oncology, Milano, Italy
Pages 23-29
|
Published online: 30 Jan 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.